
The AHA/ASA replaced 2018 stroke guidelines with expanded EVT and thrombolysis eligibility, now including basilar artery occlusion and large ischemic core patients previously excluded. Critically, aggressive BP lowering post-reperfusion and intensive glucose control are no longer recommended, reversing longstanding practice.
🩺 Clinical Considerations
- EVT now indicated for basilar artery occlusion within 24 hours with NIHSS ≥10, a major expansion from prior guidelines
- Large ischemic core volume no longer excludes patients from endovascular therapy based on improved functional outcome data
- Intensive glucose targeting (80–130 mg/dL) increases severe hypoglycemia risk without outcome benefit and is now contraindicated
- Systolic BP reduction below 140 mmHg post-thrombolysis or EVT shows no functional benefit and may cause harm after successful reperfusion
🎯 Practice Applications
- Update AIS order sets to remove intensive glucose and aggressive BP reduction targets post-reperfusion
- Review transfer protocols to ensure basilar occlusion patients reach EVT-capable centers within the 24-hour window
- Align cardiology and stroke team communication for AIS patients with concurrent cardiac conditions requiring BP management
- Incorporate mobile stroke unit partnerships into regional STEMI-equivalent response networks where available
More in Stroke
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS